• Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

F.D.A. Approves a New Antipsychotic Drug

Available antipsychotic treatments work by blocking dopamine receptors. The new drug, Cobenfy, takes a different approach.

Ellen Barry
Author: Ellen Barry

Written by

Ellen Barry

in

Clinical Trials, Dopamine, Drugs (Pharmaceuticals), Food and Drug Administration, Karuna Therapeutics Inc, Psychiatry and Psychiatrists, Psychology and Psychologists, Regulation and Deregulation of Industry, Research, Schizophrenia, Therapy and Rehabilitation
←Museum at FIT Tells the Story of the African Diaspora Through Its Fashions
Inside the U.N. Dinner Party at Eleven Madison Park→

More posts

  • Rihanna’s Beverly Hills home hit by gunfire; suspect arrested, LAPD says

  • U.S. Solar Installations Fell in 2025 as Trump Attacked Clean Energy

  • Tommy DeCarlo, Boston fan who became the band’s lead singer, dies at 60

  • Trump is delaying Texas Senate endorsement to pressure GOP senators on SAVE America Act

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube